125 related articles for article (PubMed ID: 15953202)
1. Effect of dietary fat on oral bioavailability of tepoxalin in dogs.
Homer LM; Clarke CR; Weingarten AJ
J Vet Pharmacol Ther; 2005 Jun; 28(3):287-91. PubMed ID: 15953202
[TBL] [Abstract][Full Text] [Related]
2. Single and multiple-dose pharmacokinetics of tepoxalin and its active metabolite after oral administration to rabbits (Oryctolagus cuniculus).
Pollock CG; Carpenter JW; Koch DE; Hunter RP
J Vet Pharmacol Ther; 2008 Apr; 31(2):171-4. PubMed ID: 18307510
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of tepoxalin and its active metabolite in broiler chickens.
De Boever S; Neirinckx E; Baert K; De Backer P; Croubels S
J Vet Pharmacol Ther; 2009 Feb; 32(1):97-100. PubMed ID: 19161461
[No Abstract] [Full Text] [Related]
4. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of tepoxalin in the horse: a PK/PD study.
Giorgi M; Cuniberti B; Ye G; Barbero R; Sgorbini M; Vercelli C; Corazza M; Re G
Vet J; 2011 Oct; 190(1):143-9. PubMed ID: 21036634
[TBL] [Abstract][Full Text] [Related]
6. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
[TBL] [Abstract][Full Text] [Related]
8. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
[TBL] [Abstract][Full Text] [Related]
9. Disposition of flunixin meglumine injectable preparation administered orally to healthy horses.
Pellegrini-Masini A; Poppenga RH; Sweeney RW
J Vet Pharmacol Ther; 2004 Jun; 27(3):183-6. PubMed ID: 15189304
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability and pharmacokinetics of intravenously and orally administered allopurinol in healthy beagles.
Bartges JW; Osborne CA; Felice LJ; Koehler LA; Ulrich LK; Bird KA; Chen M; Sawchuk RJ
Am J Vet Res; 1997 May; 58(5):504-10. PubMed ID: 9140559
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption.
Paulson SK; Vaughn MB; Jessen SM; Lawal Y; Gresk CJ; Yan B; Maziasz TJ; Cook CS; Karim A
J Pharmacol Exp Ther; 2001 May; 297(2):638-45. PubMed ID: 11303053
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of the Fusarium toxin deoxynivalenol (DON) from naturally contaminated wheat for the pig.
Goyarts T; Dänicke S
Toxicol Lett; 2006 Jun; 163(3):171-82. PubMed ID: 16326049
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic profiles in rats after intravenous, oral, or dermal administration of dapsone.
Helton DR; Osborne DW; Pierson SK; Buonarati MH; Bethem RA
Drug Metab Dispos; 2000 Aug; 28(8):925-9. PubMed ID: 10901702
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and oral bioavailability of pentoxyfylline in broiler chickens.
De Boever S; Baert K; De Backer P; Croubels S
J Vet Pharmacol Ther; 2005 Dec; 28(6):575-80. PubMed ID: 16343291
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of dirlotapide in the dog.
Merritt DA; Lynch MP; King VL
J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():24-32. PubMed ID: 17567512
[TBL] [Abstract][Full Text] [Related]
16. Comparative disposition of pharmacologic markers for cytochrome P-450 mediated metabolism, glomerular filtration rate, and extracellular and total body fluid volume of Greyhound and Beagle dogs.
KuKanich B; Coetzee JF; Gehring R; Hubin M
J Vet Pharmacol Ther; 2007 Aug; 30(4):314-9. PubMed ID: 17610404
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of mavacoxib in osteoarthritic dogs.
Cox SR; Liao S; Payne-Johnson M; Zielinski RJ; Stegemann MR
J Vet Pharmacol Ther; 2011 Feb; 34(1):1-11. PubMed ID: 21219337
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of the individual enantiomer S-(+)-ketoprofen after intravenous and oral administration in dogs at two dose levels.
Serrano-Rodríguez JM; Serrano JM; Rodríguez JM; Machuca MM; Gómez-Villamandos RJ; Navarrete-Calvo R
Res Vet Sci; 2014 Jun; 96(3):523-5. PubMed ID: 24746290
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of cefovecin in dogs.
Stegemann MR; Sherington J; Blanchflower S
J Vet Pharmacol Ther; 2006 Dec; 29(6):501-11. PubMed ID: 17083454
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of tepoxalin, sodium-salicylate and ketoprofen in an intravenous lipopolysaccharide inflammation model in broiler chickens.
de Boever S; Neirinckx EA; Meyer E; de Baere S; Beyaert R; de Backer P; Croubels S
J Vet Pharmacol Ther; 2010 Dec; 33(6):564-72. PubMed ID: 21062309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
